National Institute For Research In Tuberculosis

Name

National Institute For Research In Tuberculosis

Website

https://trc-chennai.org

Company type

Private

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Tuberculosis Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Tuberculosis & Mycobacterial Diseases (HLAKAGAH)

akta.pro secondary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Tuberculosis research
• Infectious disease research
• Clinical research services
• Public health research
• Biomedical research institute

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

National Institute For Research In Tuberculosis is a research institute based in Chennai, India, focused on tuberculosis research. As implied by its name and institutional character, it conducts scientific and clinical research related to TB and associated public health concerns. Specific offering details are not evidenced in the available source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Direct peers

• International Union Against Tuberculosis and Lung Disease (The Union): A century-old international scientific organization headquartered in Paris with a major TB research and operational-research portfolio. Comparable because it convenes the same TB research community, runs trials in India, and competes for the same donor funding pool.
• National JALMA Institute for Leprosy & Other Mycobacterial Diseases: A sister ICMR institute in Agra focused on mycobacterial diseases including leprosy and TB. Most directly comparable peer because it shares the same Indian government mandate, similar headcount profile, and overlapping mycobacterial research scope.
• TB Alliance: A non-profit product development partnership focused exclusively on developing and delivering better, faster-acting tuberculosis treatments. Comparable as a TB-specialized R&D organization competing for the same grant funding and trial sponsor relationships.
• FIND (Foundation for Innovative New Diagnostics): A Geneva-based non-profit driving development and evaluation of diagnostic tests for poverty-related diseases, with major TB diagnostics programs. Comparable as a TB-focused R&D and clinical-evaluation organization with similar patient-cohort and trial-site operations.

Broad incumbents

• Indian Council of Medical Research (ICMR): The apex body under India's Ministry of Health that oversees NIRT. Comparable as the broader umbrella organization with overlapping funding, ethics oversight, and research-priority-setting functions spanning all biomedical research institutes.
• CDC Division of Tuberculosis Elimination: The U.S. federal TB research and elimination program within the Centers for Disease Control. Comparable as a public-sector body with TB-specific research, surveillance, and clinical-trial functions across a national health system.
• National Institute of Allergy and Infectious Diseases (NIAID): The U.S. NIH institute with overlapping infectious-disease and TB research portfolios. Comparable as a larger, well-funded counterpart focused on TB pathogenesis, vaccine development, and clinical trials.

Regional players

• National Institute for Research in Environmental Health (NIREH): Another ICMR institute, based in Bhopal. Comparable as a sister Indian government research institute with similar operating model and funding structure, though focused on environmental health rather than TB.

Emerging players

• St. John's Research Institute (Bangalore): An Indian biomedical research institute under the St. John's National Academy of Health Sciences. Comparable as an India-based research body running infectious-disease clinical trials and translational research, though with a broader disease mandate than TB-only.
• Stanford TB Discovery Lab: An academic TB research group at Stanford Medicine focused on host-pathogen biology and therapeutics discovery. Comparable as a TB-focused research group competing for the same limited pool of international TB R&D grants and publication visibility.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/school/national-institute-for-research-in-tuberculosis

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institute For Research In Tuberculosis